Website Header with Language Selector and Dropdowns
Image

Opicapone Impurity 1


Catalog Number: CL-OPIC-07
CAS No.: 2824922-36-1
Mol.F: C16H13Cl2N3O3
Mol.W: 366.2
Inv. Status: Custom Synthesis

Chemical Name: 4-(3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-2-methoxyphenol.

Country of Origin: India

Product Category: Opicapone Impurities


Opicapone Impurity 1 is identified by CAS No. 2824922-36-1 and is chemically known as 4-(3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-2-methoxyphenol.

Opicapone Impurity 1 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Opicapone.

Page Keywords: Buy Opicapone Impurity 1 | Purchase Opicapone Impurity 1 | Opicapone Impurity 1 suppliers | Opicapone Impurity 1 manufacturers | Opicapone Impurity 1 price | Opicapone Impurity 1 Importer | Opicapone Impurity 1 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-OPIC-05
CAS No: 952091-17-7
Mol Wt: 397.2
Mol F: C15H10Cl2N4O5
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-03
CAS No: 2824922-39-4
Mol Wt: 368.2
Mol F: C15H11Cl2N3O4
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-04
CAS No: 1402714-41-3
Mol Wt: 427.2
Mol F: C16H12Cl2N4O6
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-02
CAS No: 1391712-50-7
Mol Wt: 411.2
Mol F: C16H12Cl2N4O5
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-01
CAS No: 923287-50-7
Mol Wt: 413.2
Mol F: C15H10Cl2N4O6
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-08
CAS No: 923288-59-9
Mol Wt: 234.1
Mol F: C8H9Cl2N3O
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-09
CAS No: 1402714-31-1
Mol Wt: 394.7
Mol F: C15H11ClN4O7
Inv. Status: Custom Synthesis
CAT No: CL-OPIC-06
CAS No: 1428009-72-6
Mol Wt: 493.2
Mol F: C15H10Cl2N4O9S
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.